Hologic

Photo: Ronny Siegel / Wikimedia Commons, CC BY 4.0

Hologic agrees to buy Barcelona breast cancer test maker Reveal Genomics

Reveal Genomics, a 2020 spin-off of Barcelona hospitals and the University of Barcelona, makes HER2DX, a genomic test that helps choose treatment for HER2-positive breast cancer. Hologic plans to sell it alongside its own Breast Cancer Index test.